Default: Progress in Neuro-Psychopharmacology and Biological Psychiatry

ISSN: 0278-5846

Journal Home

Journal Guideline

Progress in Neuro-Psychopharmacology and Biological Psychiatry Q1 Unclaimed

Elsevier Inc. Netherlands
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Progress in Neuro-Psychopharmacology and Biological Psychiatry is a journal indexed in SJR in Pharmacology and Biological Psychiatry with an H index of 123. It has a price of 2385 €. It has an SJR impact factor of 1,714 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -


2385 €

Gold OA


Green OA

- €

Non OA


Progress in Neuro-Psychopharmacology and Biological Psychiatry


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)



Best articles

3H-Spiperone binding to peripheral mononuclear cells in psychiatric in-patients

View more

A comparative study on the effects of tetracyclines and lithium on the cyclic amp second messenger system in rat brain

View more

A low dose of lithium chloride selectively induces fos protein in the central nucleus of the amygdala of rat brain

View more

A mathematical model for the analysis of cross-sectional brain glucose metabolism data in children

View more

A new MRI ratio method for in-vivo estimation of signal hypointensity in aging and Alzheimer's disease

View more

A novel benzodiazepine inverse agonist, S-8510, as a cognitive enhancer

View more

A preliminary study on plasma concentrations of bifemelane, indeloxazine and propentofylline in aged patients with organic brain disorders

View more

A successful clonazepam treatment without tolerance in a patient with spontaneous oral dyskinesia

View more

Acute and subchronic effects of pimozide on isolation-induced aggression in male mice

View more

Adverse neuropsychiatric events associated with dexfenfluramine and fenfluramine

View more

An ethologically based, stimulus and gender-sensitive nonhuman primate model for anxiety

View more

Aripiprazole in delusional parasitosis: Case report

View more

Association of biogenic amine metabolites with symptomatology in delusional (psychotic) and nondelusional depressed patients

View more

Attention deficit hyperactivity disorder and borderline personality disorder

View more

Auditory event-related potentials in the course of antidepressant treatment: amplitudes

View more

Caffeine enhances acute stimulant effect of morphine but inhibits morphine sensitization when assessed by ambulation of mice

View more

Changes in female cognitive performance after energetic drink consumption: A preliminary study

View more

Changes of behavior and monoamine metabolites in the rat brain after repeated methamphetamine administration: Effects of duration of repeated administration

View more

Chart review of rate of weight gain in eating disorder patients treated with tricyclic antidepressants or fluoxetine

View more

Chronic nimodipine and yawning behaviour in grouped or individually housed rats

View more

Citalopram for social phobia: a clinical case series

View more

Clinical application of time-dependent sensitization to antidepressant therapy

View more

Clinical features and alterations in the inferior horn sizes in lateral ventricle in Alzheimer's patients with different ApoE genotype in Japanese population

View more

Clotiapine: An old neuroleptic with possible clozapine-like properties

View more


No comments ... Be the first to comment!